Amyloid-beta Precursor Protein (APP) Antibody

Este producto es parte de APP - Beta-Amyloid Precursor Protein
Amyloid-beta Precursor Protein (APP) Antibody
377€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Amyloid-beta Precursor Protein (APP) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx230513
Tested Applications
ELISA, WB, IHC

Description

APP Antibody is a Mouse Monoclonal against APP.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Amyloid-beta Precursor Protein (APP)
Immunogen: amyloid beta A4 precursor protein
Host
Mouse
Reactivity
Human, Pig
Assay Type
Concentration: 2 mg/ml
Recommended Dilution
WB: 1/500 - 1/2000, IHC: 1/50 - 1/500. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG2a
Observed MW
Observed MW: 100 kDa
Purity
≥ 95% (SDS-PAGE)
Purification
Purified by Protein A and Protein G affinity chromatography.
Size 1
100 µg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P05067
Gene ID
351
Alias
AAA,AD1,PN2,ABPP,APPI,CVAP,ABETA,PN-II,preA4,CTFgamma,alpha-sAPP,Alzheimer disease amyloid protein
Background
Antibody anti-APP
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

APP is a transmembrane glycoprotein widely expressed in the brain and peripheral tissues that plays a critical role in neuronal development, synaptic plasticity, and cell adhesion APP is proteolytically processed by enzymes such as α-secretase, β-secretase, and γ-secretase, leading to the production of various fragments, including the beta-amyloid (Aβ) peptide Abnormal processing of APP and the accumulation of Aβ peptides form amyloid plaques, which are a hallmark of Alzheimer’s disease and contribute to neurotoxicity and neurodegeneration APP also interacts with various proteins to mediate intracellular signaling and cellular responses Mutations in the APP gene are associated with early-onset familial Alzheimer’s disease, highlighting its role in the pathogenesis of neurodegenerative disorders

Productos relacionados

abx002045

Amyloid Beta Precursor Like Protein 1 (APLP1) Antibody

APLP1 Antibody is a Rabbit Polyclonal antibody against APLP1. This gene encodes a member of the highly conserved amyloid…

Ver producto
abx196433

Human Amyloid-beta Precursor Protein (APP) CLIA Kit

Human Amyloid-beta Precursor Protein (APP) Chemiluminescent Immunoassay (CLIA) Kit is a Chemiluminescent Immunoassay (CL…

Ver producto
abx492330

Mouse Amyloid-beta Precursor Protein (APP) CLIA Kit

Mouse Amyloid-beta Precursor Protein (APP) Chemiluminescent Immunoassay (CLIA) Kit is a Sandwich Chemiluminescent Immuno…

Ver producto